Our findings indicate that certain plasma proteins exhibit causative roles in various hematological tumors, specifically ISOC1 in 14 tumors, ADK in 11 tumors, FKBPL in 10 tumors, and BCL2 in 9 tumors. Here, BCL2 is linked to hematopoietic and lymphoid system neoplasm.